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Vaccines that target Plasmodium falciparum gametocytes have the potential to reduce
malaria transmission and are thus attractive targets for malaria control. However, very
little is known about human immune responses to gametocytes present in human
hosts. We evaluated naturally-acquired antibodies to gametocyte-infected erythrocytes
(gametocyte-IEs) of different developmental stages compared to other asexual parasite
stages among naturally-exposed Kenyan residents. We found that acquired antibodies
strongly recognized the surface of mature asexual-IEs, but there was limited reactivity
to the surface of gametocyte-IEs of different stages. We used genetically-modified
P. falciparum with suppressed expression of PfEMP1, the major surface antigen of
asexual-stage IEs, to demonstrate that PfEMP1 is a dominant target of antibodies to
asexual-IEs, in contrast to gametocyte-IEs. Antibody reactivity to gametocyte-IEs was
similar to asexual-IEs lacking PfEMP1. Significant antibody reactivity to the surface of
gametocytes was observed when outside of the host erythrocyte, including recognition
of the major gametocyte antigen, Pfs230. This indicates that there is a deficiency
of acquired antibodies to gametocyte-IEs despite the acquisition of antibodies to
gametocyte antigens and asexual IEs. Our findings suggest that the acquisition of
substantial immunity to the surface of gametocyte-IEs is limited, which may facilitate
immune evasion to enable malaria transmission even in the face of substantial host
immunity to malaria. Further studies are needed to understand the basis for the limited
acquisition of antibodies to gametocytes and whether vaccine strategies can generate
substantial immunity.
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INTRODUCTION
Strategies to develop highly effective vaccines against malaria
remain a high priority. In particular, the development of
vaccines that interrupt malaria transmission, known as
transmission-blocking vaccines, is currently recognized as
a key goal to sustain long-term malaria elimination (1).As
such, there is a renewed interest in gametocytes, the sexual,
transmissible stages of Plasmodium falciparum, which
involves distinct parasite forms that establish infection
in the mosquito vector. Currently, the advancement of
transmission-blocking vaccines is hampered because very
little is known about immune responses to sexual-stage
antigens.
The sexual cycle of P. falciparum begins when immature
asexual blood-stage parasites undergo commitment to produce
gametocytes. The early gametocyte-IE stages (I–IV) are
sequestered and develop within organs such as the spleen and
bone marrow (2–4). Upon maturity to stage V, gametocyte-IEs
are released into the peripheral circulation and taken up by
feeding mosquitoes. During asexual development, P. falciparum
remodels the host erythrocyte through the expression of knobs
on the IE surface, which present the major surface antigen
PfEMP1 (5). Specific interactions between PfEMP1 and host
endothelial receptors enable the vascular sequestration of asexual
parasites in various microvascular beds [reviewed in (6)].
However, knobs are absent from the surface of gametocyte-IEs
(7), and PfEMP1 has not been detected on the surface of
gametocyte-IEs, suggesting that gametocyte commitment is
accompanied by the silencing of var genes (7). Other antigens
have been identified on the surface of asexual IEs (including
RIFIN, STEVOR, and SURFIN), with some evidence they are
expressed by gametocyte-IEs (8).
Antibodies against circulating gametocytes have the potential
to reduce malaria transmission efficiency by mediating
parasite clearance within the human host or inhibiting
further development of exflaggelated gametocytes within
the mosquito midgut [reviewed in (9)]. However, knowledge
of human antibodies against gametocyte-IEs is currently very
limited [reviewed in (9)]. One study reported naturally-acquired
antibodies recognized the surface of immature gametocyte-IEs
(10). In contrast, other studies reported a lack of antibodies
to immature stages, but some antibodies to mature stage
V gametocyte-IEs (11–13). The target of these antibodies
is unknown. In contrast, antibodies to gametocyte surface
antigens, such as Pfs230 and Pfs48/45, are acquired relatively
quickly and increase with cumulative exposure (14–18).
As malaria transmission may still occur despite substantial
acquired immunity to asexual parasites, it is likely that
gametocyte-IEs do not share the surface antigens that elicit this
immunity.
In order to address knowledge gaps in understanding human
transmission-blocking immunity, we quantified antibodies to
gametocyte-IEs compared to asexual IEs, and investigated the
potential basis for differences in antibody reactivity to different
developmental stages.
MATERIALS AND METHODS
A detailed description of methods is included in
Supplementary Materials.
Study Population and Ethics Statement
Plasma were collected at two study sites in Kenya (Kanyawegi
and Chulaimbo) from individuals aged 0.5–79 years, as described
(19, 20).
Ethics approval was obtained from Alfred Hospital Human
Research and Ethics Committee, Australia, Institutional
Review Board for Human Investigation at University
Hospitals of Cleveland for Case Western Reserve University,
USA and the Ethical Review Committee at the Kenya
Medical Research Institute. Written informed consent was
obtained from all study participants or their parents or legal
guardians.
P. falciparum Culture and Gametocyte
Isolation
P. falciparum was maintained in continuous culture and
synchronized as described (21). Isolates 3D7vpkd and 3D7-
SBP1KO, with inhibited PfEMP1 surface expression, were
generated as previously described (21, 22). Gametocytes
were generated according to established protocols (11, 12),
with the modification of using heparin (100 ng/mL)
throughout gametocyte development to inhibit asexual
replication (23).
Measuring Antibodies to the IE Surface
Measuring IgG binding to the IE surface was performed by flow
cytometry as previously described (21). IgG levels are expressed
as the geometric mean fluorescence intensity (MFI; arbitrary
units).
Antibodies to Recombinant Proteins
We expressed a modified form of recombinant Pfs230D1H (24),
a truncated form of Pfs230 containing the first 6-cys domain
of Pfs230 (termed Pfs230D1M) expressed in the mammalian
HEK293 cells. IgG binding to recombinant Pfs230D1M was
measured using standard ELISA methods (25).
Immunofluorescence Microscopy
Imaging of thin blood smears of stage V 3D7 gametocyte-IEs
was performed as previously described (21) and processed using
Photoshop CS6 (Adobe).
Statistical Analyses
Non-parametric analytical methods were used to evaluate
antibody results. Differences in antibody levels between
trophozoite-IEs and gametocyte-IEs were assessed using a paired
Wilcoxon signed rank test. Statistical analyses were performed
using Prism version 7 (GraphPad Software Inc).
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RESULTS
Naturally-Acquired Human Antibodies to
Gametocyte-IEs Are Markedly Lower Than
to Asexual Trophozoite-IEs
We conducted a time-course assay based on the different
developmental stages of gametocytes to assessed naturally-
acquired antibodies. Thin blood smears were prepared and
visualized by Giemsa staining to confirm the gametocyte stages
(Figure 1A). We measured the level of human antibodies to
the surface of stages II-V gametocyte-IEs by an established
flow cytometry-based assay (21) in malaria-exposed individuals
residing in Kenya (n = 21; children n = 11 and adults
n = 10), compared to antibody binding to mature pigmented
asexual trophozoite-IEs. There were noticeably low levels of
antibody reactivity to the surface of gametocyte-IEs across all
developmental stages (Figure 1B, Figure S1). Further, there was
no significant difference in antibody levels observed between
children and adults across different developmental gametocyte-
IE stages (Figure S1F). In contrast, using the same selection of
plasma samples (n = 21; children n = 11 and adults n = 10),
high antibody reactivity was measured against surface antigens
of trophozoite-IEs (Figure 1B, Figure S1). We confirmed our
findings by measuring antibodies to stage V gametocyte-
IEs in a second cohort of malaria-exposed Kenyan adults
(n = 20; Figure S2). Similarly, all individuals had markedly
lower antibody levels to stage V gametocyte-IEs compared
to trophozoite-IEs (Figures S2A,B). Furthermore, increasing
the plasma concentration from both human cohorts (1:2
dilution) used in assays did not substantially increase reactivity
(Figures S2C,D). Our findings show that antibodies induced
during natural malaria exposure have little reactivity to the
surface of gametocyte-IEs across all stages.
PfEMP1-Dominant Antibody Response in
Asexual Trophozoite-IEs Contrasts the
Low Response to Stage V Gametocyte-IEs
We hypothesized that the high reactivity to trophozoite-IEs,
compared to gametocyte-IEs may be explained by antibodies
targeting PfEMP1. Using genetically-modified P. falciparum with
suppressed PfEMP1 expression, we found that PfEMP1 was a
dominant target of naturally-acquired antibodies to the surface
of asexual trophozoite-IEs (Figures 1C,D, Figure S3A) using
the same selection of plasma samples from Kenyan children
and adults (n = 21; children n = 11 and adults n = 10).
This is consistent with our previous reports (21, 22). This was
demonstrated by the greatly reduced reactivity of antibodies to
3D7vpkd and 3D7-SBP1KO IEs compared to 3D7 parental IEs.
To better understand the magnitude of antibody responses to
gametocyte-IEs, we compared antibodies to stage V gametocyte-
IEs with asexual trophozoite-IEs that have reduced PfEMP1
expression (using 3D7vpkd and 3D7-SBP1KO). The level of
antibodies to stage V gametocyte-IEs were substantially lower
compared to trophozoite-IEs from 3D7 parental (71.1% lower;
Figures 1C,D; p < 0.0001) and 3D7vpkd (55.9% lower; p <
0.0001). There was minimal difference in antibody levels to stage
V gametocyte-IEs and 3D7-SBP1KO (p = 0.02). Prior studies
suggested that there is still low levels of PfEMP1 expression
on the surface of 3D7vpkd IEs (21, 22), which may explain
the higher antibody reactivity to 3D7vpkd compared to 3D7-
SBP1KO and gametocyte-IEs. These findings suggested that the
lack of PfEMP1 on gametocyte-IEs is likely to be a major reason
for the low reactivity of antibodies compared to trophozoite-
IEs.
Gametocytes Without the IE Membrane
Are Recognized by Acquired Human
Antibodies
We quantified the level of naturally-acquired antibodies to
surface antigens expressed on the gametocyte plasma membrane.
The IE membrane was removed by saponin treatment, and
thin blood smears with Giemsa staining was used to confirm
that gametocytes remained intact post-saponin treatment
(Figure 2A). The level of antibodies to 3D7 stage V gametocytes
and gametocyte-IEs was measured in a subset of Kenyan
individuals (n = 5 from samples tested in Figure 1; children
n = 3 and adults n = 2). High levels of antibodies were
observed to 3D7 gametocytes, but not 3D7 gametocyte-
IEs (Figures 2B,C, Figure S3B; reactivity 92.3% higher; p =
0.06).
To further assess antibodies to gametocytes, we measured
antibodies to recombinant Pfs230, a major gametocyte surface
antigen and vaccine candidate (24). We measured IgG reactivity
in the same selection of Kenyan individuals used in assays of
trophozoite-IEs and gametocyte-IEs (n = 21 from Figure 1;
children n = 11 and adults n = 10). The majority of
individuals (80.9%) were positive for antibodies to Pfs230D1M
(Figure 2D; Figure S4) and there was a positive correlation
between IgG binding to Pfs230D1M and to whole gametocytes
(rs = 0.9; Figure 2E). Further, immunofluorescence microscopy
demonstrated that anti-Pfs230 rabbit antibody labeled native
Pfs230 expressed on the surface of stage V gametocytes
(Figure 2F). Together, these findings suggest that individuals
do acquire antibodies to sexual stage parasites, but there is
very limited acquisition of antibodies target antigens on the
gametocyte-IE surface.
DISCUSSION
There was limited acquisition of antibodies to antigens on
the surface of gametocyte-IEs, despite study subjects having
high levels of antibodies to asexual trophozoite-IEs, as well as
substantial antibody reactivity to the major gametocyte antigen,
Pfs230. This finding was observed throughout different stages of
gametocyte development. Our findings suggested that the lack
of PfEMP1 on gametocyte-IEs may be a key explanation for
the low antibody reactivity that contrasts the high reactivity to
trophozoite-IEs. We demonstrated that the antibody response
to asexual trophozoite-IEs is PfEMP1-dominant, with low levels
of antibodies measured to genetically-modified trophozoite-IEs
with suppressed PfEMP1 expression. Furthermore, antibody
levels to gametocyte-IEs were comparable to trophozoite-IEs that
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FIGURE 1 | Low levels of naturally-acquired antibodies to the surface of gametocyte-IEs. (A) Giemsa-stained smears confirm the respective gametocyte-IE stages.
(B) Total IgG binding to the surface of trophozoite-IEs and gametocyte-IEs was measured at stages II–V of gametocyte development. Samples were from
malaria-exposed Kenyan individuals (children n = 11 and adults n = 10). The dotted line represents the antibody positivity threshold (MFI levels greater than mean +
3SD of non-exposed Melbourne controls). IgG binding levels are expressed as geometric mean fluorescence intensity (MFI) for all graphs; assays were performed
thrice independently, with samples measured in duplicate (n = 21); bars represent mean and standard deviation. (C) A representative selection of plasma samples
tested for antibodies to trophozoite-IEs and gametocyte-IEs. 3D7vpkd and 3D7-SBP1KO are transgenic parasite lines with inhibited PfEMP1 surface expression
through the suppression of endogenous var genes (var promoter “knock-down”; vpkd) (21, 26) or genetic deletion of the PfEMP1 trafficking protein (skeleton-binding
protein 1 “knock-out”; SBP1KO) (22, 27, 28); these were used at the asexual mature trophozoite stage. Samples were from malaria-exposed Kenyan individuals (CX;
children n = 11 and adults n = 10) and non-exposed Melbourne residents (Control). IgG binding to gametocyte-IEs was substantially lower in all individuals compared
to IgG binding to trophozoite-IEs. There was minimal background reactivity observed among sera from Melbourne residents; the dotted line represents the antibody
positivity threshold. Assays were performed thrice independently; bars represent mean and range of samples tested in duplicate. (D) IgG binding to the surface of
stage V 3D7 gametocyte-IEs was substantially lower compared to trophozoite-IEs of 3D7 parental and 3D7vpkd. The difference in IgG binding between
gametocyte-IEs and trophozoite-IEs of 3D7 SBP1KO was minimal in our sample set. The dotted line represents the antibody positivity threshold (MFI levels greater
than mean + 3SD of non-exposed Melbourne controls). Assays were performed thrice independently; bars represent median and interquartile ranges of samples
tested in duplicate (n = 21; children n = 11 and adults n = 10); p-values were calculated using a paired Wilcoxon signed rank test.
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FIGURE 2 | Antibodies recognize the surface of gametocytes in contrast to gametocyte-IEs. (A) Giemsa smears of gametocytes (without the erythrocyte membrane)
and intact gametocyte-IEs that were used in antibody assays. (B) IgG binding to 3D7 gametocytes (without the erythrocyte membrane) was markedly higher
compared to intact gametocyte-IEs. Assays were performed thrice independently; bars represent median and interquartile ranges of samples tested in duplicates (n =
5; children n = 3, adults n = 2); p-value was calculated using a paired Wilcoxon signed rank test. The dotted line represents the antibody positivity threshold (MFI
levels greater than mean + 3SD of non-exposed Melbourne controls). (C) A representative selection of plasma samples tested for antibodies to 3D7 gametocytes and
intact gametocyte-IEs. Samples were from malaria-exposed Kenyan individuals (CX; children n = 3, adults n = 2), and non-exposed Melbourne residents (Control).
IgG binding to 3D7 gametocytes was substantially higher in all individuals compared to IgG binding to intact gametocyte-IEs. There was minimal background reactivity
observed among sera from Melbourne residents; the dotted line represents the antibody positivity threshold. Assays were performed thrice independently; bars
represent mean and range of samples tested in duplicate. (D) A representative selection of plasma samples were tested for total IgG binding to recombinant
Pfs230D1M. The same selection of samples measured by flow cytometry (n = 21; children n = 11 and adults n = 10) was used. Antibody levels are expressed in
(Continued)
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FIGURE 2 | optical density (OD) measured at 450 nm. Assays were performed twice; bars represent mean and range of samples tested in duplicate (n = 21); the
dotted line represents the antibody positivity threshold. (E) There was a strong positive (non-significant) correlation between total IgG binding measured by flow
cytometry (MFI) to 3D7 gametocytes and by ELISA (OD450 nm) to recombinant Pfs230D1M. Correlations were evaluated using Spearman’s rho (r). (F)
Immunofluorescence microscopy demonstrates the recognition of the native gametocyte surface by a Pfs230-specific antibody (green). Cells were fixed with 90%
acetone and 10% methanol, and DAPI was used to stain nuclear DNA (blue). Representative images are shown.
largely lack PfEMP1. Interestingly, when the IE membrane was
removed from stage V gametocytes, acquired antibodies had
good reactivity to the gametocyte plasma membrane, indicating
that the limited antibody reactivity to gametocyte-IEs was
specific to IE surface antigens. Limited antibody acquisition to
gametocyte-IEs may be an immune evasion strategy to enable
malaria transmission to occur in the face of developing immunity
(11, 15, 29, 30). The low or absent expression of PfEMP1 on
gametocytes (8) may facilitate this immune evasion given that
PfEMP1 is a dominant target of acquired immunity during
blood-stage infection (6, 21, 22).
Naturally-acquired antibodies to trophozoite-IEs
predominantly target PfEMP1 (21, 22), presented on the IE
surface by knob structures (5). However, electron microscopy
studies showed that gametocyte-IEs of all stages do not modify
the IE surface with knobs, consistent with the absence of the
essential knob component, KAHRP (7). Further, var gene
transcription is downregulated at the onset of gametocyte
differentiation, consistent with reports of the absence of
detectable surface-exposed PfEMP1 in all stages of gametocyte-
IEs (7). The lack of PfEMP1 expression on gametocyte-IEs
likely explains the low antibody reactivity observed. As PfEMP1
is the main target of antibodies in asexual trophozoite-IEs,
the downregulation of PfEMP1 in gametocyte-IEs may be an
immune evasion mechanism to prevent clearance by antibodies.
That gametocytes develop within erythrocytes, which lack MHC
class-I, may further facilitate immune evasion. Furthermore,
gametocyte development occurs predominantly in the bone
marrow which may also be a factor influencing the acquisition of
antibodies.
Interestingly, when the IE membrane was removed from
the gametocytes, human antibodies recognized native antigens
expressed on the gametocyte membrane itself, consistent
with other reports on permeabilized gametocyte-IEs (13).
Major gametocyte surface antigens include Pfs230 and
Pfs48/45, which are targeted by human antibodies and
associated with transmission-blocking activity through
mosquito feeding assays [reviewed in (9)]. We found that
the majority of samples tested in our study had high levels
of IgG to recombinant Pfs230, suggesting that there was
substantial acquisition of antibodies to gametocytes, but
not gametocyte-IEs. Further, antibody levels measured to
recombinant Pfs230 correlated with those against whole
gametocytes.
Prior studies of gametocyte-IEs have reported some
acquisition of antibodies mature stage V gametocyte-IEs
(11, 12), although the prevalence of these antibodies was
generally low. Differences in reactivity to stage V gametocyte-IEs
between studies may relate to differences in sample populations
and timing of sampling relative to infection episodes, including
the presence of active gametocytemias. The focus of our study
was to evaluate antibodies to gametocyte-IEs and understand
the basis for the different reactivity between trophozoite-IEs and
gametocyte-IEs. Future studies are needed to better understand
antibodies to mature stage V gametocyte-IEs in different
populations (age and geography) with different infection status
and exposure history. It is possible that antibodies to gametocyte-
IEs could be very short-lived, or antigens expressed could be
transient in nature or weakly immunogenic, therefore requiring
specific study designs to detect them. Our studies were limited to
using the 3D7 P. falciparum isolate, and further work to evaluate
antibodies to the surface of gametocyte-IEs of other isolates,
especially recent clinical isolates, is warranted.
In conclusion, the limited acquisition of antibodies targeting
gametocyte-IEs contrasts with the PfEMP1-dominant antibody
response toward asexual trophozoite-IEs. Reactivity to
gametocyte-IEs was comparable to the low antibody reactivity
observed against trophozoite-IEs lacking PfEMP1. However,
human antibodies were acquired against the surface of intact
gametocytes and to Pfs230. The deficiency in acquired antibodies
to gametocyte-IEs could be an important mechanism to
avoid clearance by host immunity. Our findings provide
new insights to address the major knowledge gaps in
understanding immunity and malaria transmission, which
will help inform the development of transmission-blocking
vaccines.
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